Evidence map›Paper›PMID 36736870›Full record

ArticleBiological psychiatry2023

Impaired Endogenous Neurosteroid Signaling Contributes to Behavioral Deficits Associated With Chronic Stress.

Najah L Walton, Pantelis Antonoudiou, Lea Barros, Tauryn Dargan, Alyssa DiLeo, Aidan Evans-Strong, Jenah Gabby, Samantha Howard, Rumzah Paracha, Edgardo J Sánchez and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Biological psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Chronic stress enhances threat responding and impacts fear extinction.Learning & memory (Cold Spring Harbor, N.Y.) · 2026
    Article
  6. Article
  7. Article
  8. Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Najah L WaltonDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Pantelis AntonoudiouDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Lea BarrosDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts; Building Diversity in Biomedical Sciences Program, Tufts University School of Medicine, Boston, Massachusetts; Department of Biology, Hamilton College, Clinton, New York.
Tauryn DarganDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Alyssa DiLeoDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Aidan Evans-StrongDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Jenah GabbyDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts; Building Diversity in Biomedical Sciences Program, Tufts University School of Medicine, Boston, Massachusetts; Louis Stokes Alliance for Minority Participation, Tufts University, Medford, Massachusetts.
Samantha HowardDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts; Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts; F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Rumzah ParachaDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Edgardo J SánchezDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts; Building Diversity in Biomedical Sciences Program, Tufts University School of Medicine, Boston, Massachusetts; Department of Chemistry, University of Puerto Rico, Cayey, Puerto Rico.
Grant L WeissDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts.
Dong KongDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts; Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts; F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Jamie L MaguireDepartment of Neuroscience, Program of Neuroscience, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts. Electronic address: Jamie.Maguire@tufts.edu.
Tufts University · US

Funding

Transgenic CoreP30DK046200 · NIDDK · TUFTS MEDICAL CENTER · PI CORKEY, BARBARA E. · 1992 to 2021
$25.0M
Neuroactive steroids as novel psychiatric treatments: mechanistic studiesP50MH122379 · NIMH · WASHINGTON UNIVERSITY · PI MAGUIRE, JAMIE LYNN · 2021 to 2025
$12.2M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Investigating the pathological consequences of seizure-induced activation of the HPA axisR01NS102937 · NINDS · TUFTS UNIVERSITY BOSTON · PI Jamie Lynn Maguire · 2017 to 2026
$4.2M
Stress-induced impairments in endogenous neurosteroid signaling in the BLA negatively impacts network and behavioral statesR01MH128235 · NIMH · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2021 to 2025
$2.5M
A Neural Circuit of Energy Expenditure Preventing ObesityR01DK108797 · NIDDK · TUFTS UNIVERSITY BOSTON · PI KONG, DONG · 2016 to 2020
$2.3M
Astrocyte-derived lactate modulates orexinergic neuron activity and behaviorR01NS107315 · NINDS · TUFTS UNIVERSITY BOSTON · PI HAYDON, PHILIP G, KONG, DONG · 2018 to 2022
$2.0M
Interneurons tune the neural circuits mediating the anxiolytic effects of alcoholR01AA026256 · NIAAA · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2018 to 2022
$1.9M
Disruption in the network communication of safety in epilepsy with comorbid anxietyR01NS105628 · NINDS · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2019 to 2022
$1.6M
Research Training Program in Nutrition, Obesity and Metabolic DisordersT32DK124170 · NIDDK · TUFTS UNIVERSITY BOSTON · PI GREENBERG, ANDREW S · 2020 to 2024
$870k
ACSL4 on the interface of metabolism and mental healthR21HD098056 · NICHD · TUFTS UNIVERSITY BOSTON · PI KONG, DONG · 2018 to 2019
$444k
NIAAA NIH HHS R01 AA026256NICHD NIH HHS P50 HD105351NICHD NIH HHS R21 HD098056NIDDK NIH HHS P30 DK046200NIDDK NIH HHS R01 DK108797NIDDK NIH HHS T32 DK124170NIMH NIH HHS P50 MH122379NIMH NIH HHS R01 MH128235NINDS NIH HHS R01 NS102937NINDS NIH HHS R01 NS105628NINDS NIH HHS R01 NS107315
6 · The paper itself

Abstract

backgroundChronic stress is a major risk factor for psychiatric illnesses, including depression. However, the pathophysiological mechanisms whereby stress leads to mood disorders remain unclear. Allopregnanolone acts as a positive allosteric modulator preferentially on δ subunit-containing GABA

methodsWe utilized a chronic unpredictable stress (CUS) mouse model, followed by behavioral and biochemical assays, to examine whether altered neurosteroid signaling contributes to behavioral outcomes following CUS. We subsequently performed in vivo CRISPR (clustered regularly interspaced short palindromic repeats) knockdown of rate-limiting enzymes involved in allopregnanolone synthesis, 5α-reductase type 1 and 2 (5α1/2), in addition to lentiviral overexpression of 5α1/2 in the basolateral amygdala (BLA) of mice that underwent CUS to assess the impact of 5α1/2 on behavioral outcomes.

resultsThe expression of δ subunit-containing GABA

conclusionsOur findings demonstrate that chronic stress impairs endogenous neurosteroid signaling in the BLA, which is sufficient to induce behavioral deficits. Further, these studies suggest that allopregnanolone-based treatments may directly target the underlying pathophysiology of mood disorders suggesting that targeting endogenous neurosteroidogenesis may offer a novel therapeutic strategy.

Indexed as

NeurosteroidsPregnanoloneAnimalsgamma-Aminobutyric AcidMiceReceptors, GABA-ASignal Transductiongamma-Aminobutyric AcidNeurosteroidsPregnanoloneReceptors, GABA-AAllopregnanoloneDepressionGABANeurosteroidogenesisNeurosteroidsStress

Identifiers

PMID36736870
PMCPMC10363189
OpenAlexW4318829320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.